Related sites
الخط الساخن للخدمات الصحية للنازحين اللبنانيين 1787   
الخط الساخن لدخول المرضى الى المستشفيات 01/832700   
التسجيل لأخذ لقاح الكورونا covax.moph.gov.lb   
الخط الساخن لوزارة الصحّة العامة 1214   
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

إحصاءات نظام إبلاغ أسباب الوفيات من المستشفيات

A National Hospital Based Mortality Notification system (HMS) was established at the beginning of 2017 in collaboration with the World Health Organization and in cooperation with the Syndicate of hospitals as an expansion of the maternal and neonatal death reporting system established in 2011. The system consists of anonymous online reporting of deaths based on an excerpt of the official death certificate form. Focal points were assigned and trained in more than 150 public and private hospitals operating in Lebanon. After reporting the information, quality checks are initiated through constant communication between the statistics department and the hospitals’ focal points. After that, the underlying cause of death is selected from the reported causes of the death.
 
 
Hospital Mortality Statistics 2025
Hospital Deaths due to COVID-19 by Week, 2020-2025 (till August 2025)​


Hospital Deaths due to COVID-19 by Month, 2020-2025 (till August 2025)​
 
 
Hospital Mortality Statistics 2024
 
Number of reported hospital deaths and proportional mortality due to malignant neoplasms, 2017-2024

Top Cancer Killers In Men and Women,2024
 
Hospital Mortality Statistics 2022
Top Cancer Killers in Men and Women, 2022
 
Hospital Mortality Statistics 2021
Number of reported Lebanese hospital deaths by month and age group


Number of reported hospital deaths by month and age group in Lebanon



Number of reported COVID-19 hospital deaths by month and age group


Weekly Total Hospital Deaths and COVID19 Related Deaths

 
Hospital Mortality Statistics 2020 and 2021
Weekly Total Hospital Deaths and COVID19 Related Deaths 2020​​&2021

 

 
Hospital Mortality Statistics 2020
Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group in Lebanon

Weekly Total Hospital Deaths and COVID19 Related Deaths

 
Hospital Mortality Statistics 2019
Number of reported Lebanese hospital deaths by month and age group, 2019

Number of reported hospital deaths by month and age group in Lebanon, 2019 (Updated)​
 
 
Hospital Mortality Statistics 2018
Number of reported Lebanese hospital deaths by month and age group, 2018


Number of reported hospital deaths by month and age group in Lebanon, 2018 ​
 
Hospital Mortality Statistics 2017
Number of reported Lebanese hospital deaths by month and age group, 2017


Number of reported hospital deaths by month and age group in Lebanon, 2017

Reported hospital deaths by top ICD10 chapters, 2017  
 


Top 10 cancers by ICD10 3-character code, 2017​
 


Plot of the number of the reported deaths by size and type of hospital, 2017



Five leading cancer deaths by gender, 2017
 


Top 10 leading causes of reported hospital deaths by ICD10 4-character code and gender, 2017
 
 

Proportion of reported hospital deaths by age group and gender in Lebanon, 2017 

 
 
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
D07XC04 TRAVOCORT B Diflucortolone valerate - 0.1%, Isoconazole nitrate - 1% Cream 435,405 L.L
L04AX07 TECFEO 240 G Dimethyl Fumarate - 240mg 240mg Capsule, delayed release L.L
L04AX07 TECFEO 240 G Dimethyl Fumarate - 240mg 240mg Capsule, delayed release 67,784,092 L.L
J07CA02 TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé) B Diphteria toxoid purified - ≥30IU, Tetanus toxoid purified - ≥40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg Injectable suspension 1,628,737 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 20mg/ml 20mg/ml Injectable concentrated solution+diluent 6,574,078 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 20mg/ml 20mg/ml Injectable concentrated solution+diluent 6,574,078 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 80mg/4ml 80mg/4ml Injectable concentrated solution+diluent 24,150,868 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 80mg/4ml 80mg/4ml Injectable concentrated solution+diluent 24,150,868 L.L
J05AX12 TIVICAY B Dolutegravir - 50mg 50mg Tablet, film coated 54,508,037 L.L
J05AR13 TRIUMEQ B Dolutegravir - 50mg, Abacavir sulfate - 600mg, Lamivudine - 300mg Tablet, film coated 74,756,237 L.L
S01ED51 TWINZOL G Dorzolamide HCl - 2%, Timolol - 0.5% Drops solution 632,950 L.L
J01AA02 TOLEXINE G Doxycycline (monohydrate) - 100mg 100mg Tablet, microgranules 589,947 L.L
R05CA12 TOUCALM G Dried Ivy leaf extract - 0.7g/100ml 0.7g/100ml Syrup 300,765 L.L
S01XA20 TEARS NATURALE B Duasorb - 0.4% 0.4% Drops solution 189,482 L.L
A10BJ05 TRULICITY BioTech Dulaglutide - 0.75mg/0.5ml 0.75mg/0.5ml Injectable solution 10,165,201 L.L
A10BJ05 TRULICITY BioTech Dulaglutide - 1.5mg/0.5ml 1.5mg/0.5ml Injectable solution 10,165,201 L.L
J05AR03 TRUVADA B Emtricitabine - 200mg, Tenofovir disoproxil - 245mg Tablet, film coated 21,319,383 L.L
L01EB02 TARESSA 100 G Erlotinib (HCl) - 100mg 100mg Tablet, film coated 82,247,256 L.L
L01EB02 TARESSA 150 G Erlotinib (HCl) - 150mg 150mg Tablet, film coated 98,617,813 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40μmol/ml Injectable powder for solution + solution 53,437,592 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40μmol/ml Injectable powder for solution + solution 24,369,850 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40μmol/ml Injectable powder for solution + solution 13,394,024 L.L
R01AD08 TICANASE G Fluticasone propionate - 50mcg/actuation 12g/Bottle Spray, suspension 405,840 L.L
D07CC01 TOPIZONE G Fusidic acid - 20mg/g, Betamethasone (valerate) - 1mg/g Cream 216,359 L.L
S01AE06 TYMER G Gatifloxacin (sesquihydrate) - 3mg/ml 3mg/ml Drops solution 427,342 L.L
C05CX TANAKAN B Ginkgo biloba - 40mg 40mg Tablet, film coated 661,171 L.L
C05CX TANAKAN B Ginkgo biloba - 40mg 40mg Tablet, film coated 1,662,333 L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution 190,195,151 L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution 190,195,151 L.L
L04AC16 TREMFYA BioTech Guselkumab - 100mg/ml 100mg/ml Injectable solution L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025